Skip to main content
QNCX logo

QNCX

Quince Therapeutics, Inc.
$19.29 +2.04 (+11.83%) At close · Jul 14
Market Cap
$296.35M
Shares
16,300,740

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 48
Total Value: $294,877,799
Total Shares: 15,307,662

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 48 13F filers · Δ vs Dec 31, 2025
Top Holder
35.6%
Jun 2023 → Mar 2026 · range 13.2% – 46.6%
+22.4 pts
Top 5
82.4%
Jun 2023 → Mar 2026 · range 50.1% – 82.4%
+32.3 pts
Top 10
94.1%
Jun 2023 → Mar 2026 · range 70.0% – 94.1%
+24.0 pts
HHI
1,921
Jun 2023 → Mar 2026 · range 656 – 2,552
Moderately concentrated+1,266

Quarterly Activity

vs Dec 31, 2025
New
17
Increased
9
Decreased
12
Sold Out
36
Unchanged
10
Holder count: -19
Institutional value: -97.8%
Shares held: -24.4%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 52 of 52
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1662774 CUSIP 22053A206 13F (30d) 1 filings 1 filers Visit website Investor relations